Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. Estrone Sulfate
2. Estrone Sulfate, 14c-labeled
3. Estrone Sulfate, 16-(14)c-labeled
4. Estrone Sulfate, Ammonium Salt
5. Estrone Sulfate, Potassium Salt
6. Estrone Sulfate, Sodium Salt
7. Estrone-3-sulfate
8. Evex
9. Oestrone Sulphate
10. Potassium Estrone Sulfate
11. Sodium Estrone Sulfate
1. Sodium Estrone Sulfate
2. Estrone Sodium Sulfate
3. 438-67-5
4. Estrone Sodium Sulphate
5. Estrone 3-sulfate Sodium Salt
6. Conestoral
7. Hyhorin
8. Morestin
9. Estrone Sulfate Sodium
10. Par Estro
11. Estrone Sulfate Sodium Salt
12. Estrone-3-sulfate Sodium Salt
13. Sodium Estrone Sulphate
14. Sodium Estrone 3-sulfate
15. Oestrone-3-sulphate Sodium Salt
16. Estrogenic Substances (conjugated)
17. Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, Sodium Salt
18. 6k6fda543a
19. Chebi:8389
20. 17-oxoestra-1,3,5(10)-trien-3-yl Sodium Sulfate
21. Nsc-18313
22. Estrone Sulfate (sodium)
23. Sodium;[(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Sulfate
24. Sodium Estrone-3-sulfate
25. 1,3,5(10)-estratrien-3-ol-17-one Sulphate, Sodium Salt
26. Smr000058772
27. Einecs 207-120-4
28. Nsc 18313
29. Unii-6k6fda543a
30. Conjugated Estrogens: Sodium Estrone Sulfate
31. Estrone3-sulfatesodiumsalt
32. Sodium (8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta(a)phenanthren-3-yl Sulfate
33. Sodium (8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-yl Sulfate
34. Sodium 17-oxoestra-1(10),2,4-trien-3-yl Sulfate
35. Estrone, Hydrogen Sulfate, Sodium Salt
36. Schembl4616
37. Mls000069757
38. Mls001424259
39. Chembl2106240
40. Dtxsid00860005
41. Dtxsid70881181
42. Hms2052j05
43. Hms2232j23
44. Discontinued. See E889070
45. Akos015967195
46. Estrone Sodium Sulfate [vandf]
47. Ccg-101163
48. Hy-113293b
49. Nc00413
50. Estrone Sodium Sulfate [who-dd]
51. Cs-0108249
52. D00312
53. Q4118295
54. Sodium 17-oxoestra-1,3,5(10)-trien-3-yl Sulfate
55. Estrone 3-sulfate Sodium Salt, Stabilized With Tris
56. Estra-1,3,5(10)-trien-17-one 3-(sulfooxy) Sodium Salt
57. Sodium [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Sulfate
Molecular Weight | 372.4 g/mol |
---|---|
Molecular Formula | C18H21NaO5S |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 372.10073922 g/mol |
Monoisotopic Mass | 372.10073922 g/mol |
Topological Polar Surface Area | 91.9 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 630 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Premarin |
PubMed Health | Conjugated Estrogens (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Musculoskeletal Agent |
Drug Label | Premarin Intravenous (conjugated estrogens, USP) for injection contains a mixture of conjugated estrogens obtained exclusively from natural sources, occurring as the sodium salts of water-soluble estrogen sulfates blended to represent the average com... |
Active Ingredient | Estrogens, conjugated |
Dosage Form | Tablet; Cream; Injectable |
Route | oral; Injection; Oral; Topical, vaginal |
Strength | 25mg/vial; 0.45mg; 1.25mg; 0.625mg/gm; 0.625mg; 0.9mg; 0.3mg |
Market Status | Prescription |
Company | Wyeth Pharms |
2 of 2 | |
---|---|
Drug Name | Premarin |
PubMed Health | Conjugated Estrogens (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Musculoskeletal Agent |
Drug Label | Premarin Intravenous (conjugated estrogens, USP) for injection contains a mixture of conjugated estrogens obtained exclusively from natural sources, occurring as the sodium salts of water-soluble estrogen sulfates blended to represent the average com... |
Active Ingredient | Estrogens, conjugated |
Dosage Form | Tablet; Cream; Injectable |
Route | oral; Injection; Oral; Topical, vaginal |
Strength | 25mg/vial; 0.45mg; 1.25mg; 0.625mg/gm; 0.625mg; 0.9mg; 0.3mg |
Market Status | Prescription |
Company | Wyeth Pharms |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27920
Submission : 2014-02-19
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34883
Submission : 2020-06-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3853
Submission : 1980-06-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2774
Submission : 1976-10-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3011
Submission : 1977-08-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13962
Submission : 1999-01-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2767
Submission : 1976-11-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 934
Submission : 1965-12-08
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7328
Submission : 1988-02-09
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12639
Submission : 1997-09-02
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Avion Pharmaceuticals gets exclusive rights to relaunch Cenestin® in the USA. Cenestin® is the only plant-derived mixture of nine conjugated estrogens indicated for treatment of moderate to severe symptoms of vasomotor, and vulvar and vaginal atrophy due to menopause.
Lead Product(s): Conjugated Estrogens
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Cenestin
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Avion Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 12, 2020
Lead Product(s) : Conjugated Estrogens
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Avion Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
Aspen Concludes Strategic Partnership with U.S-Based Avion Pharmaceuticals
Details : Avion Pharmaceuticals gets exclusive rights to relaunch Cenestin® in the USA. Cenestin® is the only plant-derived mixture of nine conjugated estrogens indicated for treatment of moderate to severe symptoms of vasomotor, and vulvar and vaginal atrophy d...
Brand Name : Cenestin
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 12, 2020
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC A
Brand Name : CENESTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2002-06-21
Application Number : 20992
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC A
Brand Name : CENESTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1999-03-24
Application Number : 20992
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC A
Brand Name : CENESTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.9MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1999-03-24
Application Number : 20992
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC A
Brand Name : CENESTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2000-03-13
Application Number : 20992
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC A
Brand Name : CENESTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 0.45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2004-02-05
Application Number : 20992
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC B
Brand Name : ENJUVIA
Dosage Form : TABLET;ORAL
Dosage Strength : 0.3MG
Packaging :
Approval Date : 2004-12-20
Application Number : 21443
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC B
Brand Name : ENJUVIA
Dosage Form : TABLET;ORAL
Dosage Strength : 0.45MG
Packaging :
Approval Date : 2004-12-20
Application Number : 21443
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC B
Brand Name : ENJUVIA
Dosage Form : TABLET;ORAL
Dosage Strength : 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2004-05-10
Application Number : 21443
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC B
Brand Name : ENJUVIA
Dosage Form : TABLET;ORAL
Dosage Strength : 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2004-05-10
Application Number : 21443
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ESTROGENS, CONJUGATED SYNTHETIC B
Brand Name : ENJUVIA
Dosage Form : TABLET;ORAL
Dosage Strength : 0.9MG
Packaging :
Approval Date : 2007-04-27
Application Number : 21443
Regulatory Info : DISCN
Registration Country : USA
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?